ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009

NCI Offers Model Informed Consent Documents

November 6, 1998

Treatment IND or GM-CSF Is Approved

October 5, 1990

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted

October 27, 1978